journal article·2023-03-08

Highly Penetrable Drug-Loaded Nanomotors for Photothermal-Enhanced Ferroptosis Treatment of Tumor

Yawen Zhang, Ke Zhang, Hongna Yang, Yijie Hao, Jinzha Zhang, Wenbo Zhao, Shirong Zhang, Shenglin Ma, Chun Mao

Publisher page

Abstract

A kind of drug-loaded nanomotors with deep penetration was developed to improve the therapeutic effect of ferroptosis on tumor. The nanomotors were constructed by co-loading hemin and ferrocene (Fc) on the surface of bowl-shaped polydopamine (PDA) nanoparticles. The near-infrared response of PDA makes the nanomotor have high tumor penetration capability. In vitro experiments show that the nanomotors can exhibit good biocompatibility, high light to heat conversion efficiency, and deep tumor permeability. It is worth noting that under the catalysis of H 2 O 2 overexpressed in the tumor microenvironment, the Fenton-like reagents hemin and Fc loaded on the nanomotors can increase the concentration of toxic •OH. Furthermore, hemin can consume glutathione in tumor cells and trigger the up-regulation of heme oxygenase-1, which can efficiently decompose hemin to Fe 2+, thus producing the Fenton reaction and causing a ferroptosis effect. Notably, thanks to the photothermal effect of PDA, it can enhance the generation of reactive oxygen species and thus intervene in the Fenton reaction process, thereby enhancing the ferroptosis effect photothermally. In vivo antitumor results show that the drug-loaded nanomotors with high penetrability showed an effective antitumor therapeutic effect.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Micro and Nano Robotics · Nanoplatforms for cancer theranostics · Genetic and Kidney Cyst Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, Jiangsu 210023, China

Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310006, China

Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Cancer Center, School of Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University, Hangzhou, Zhejiang 310006, China

Funding

Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials · National Natural Science Foundation of China · Hangzhou Science and Technology Bureau · Priority Academic Program Development of Jiangsu Higher Education Institutions · Natural Science Foundation of Zhejiang Province · Zhejiang Medical and Health Science Project

References (42)

Show source-provided references
1. 10.1038/s41586-020-2623-z10.1038/s41586-020-2623-z ↗
2. 10.1038/s41586-020-2732-810.1038/s41586-020-2732-8 ↗
3. 10.1016/j.cell.2020.04.03910.1016/j.cell.2020.04.039 ↗
4. 10.1007/s11426-021-1208-610.1007/s11426-021-1208-6 ↗
5. 10.1002/smll.20220033010.1002/smll.202200330 ↗
6. 10.1002/adfm.20211178410.1002/adfm.202111784 ↗
7. 10.1126/sciadv.abj883310.1126/sciadv.abj8833 ↗
8. 10.1002/ange.20211722910.1002/ange.202117229 ↗
9. 10.1021/acsnano.1c0677710.1021/acsnano.1c06777 ↗
10. 10.1021/acsnano.1c0866410.1021/acsnano.1c08664 ↗
11. 10.1021/acsnano.0c0641510.1021/acsnano.0c06415 ↗
12. 10.1016/j.jconrel.2020.01.00810.1016/j.jconrel.2020.01.008 ↗
13. 10.1016/j.biomaterials.2020.11997610.1016/j.biomaterials.2020.119976 ↗
14. 10.1016/j.jcis.2022.11.09910.1016/j.jcis.2022.11.099 ↗
15. 10.1016/j.cej.2021.13079010.1016/j.cej.2021.130790 ↗
16. 10.1002/adma.20220665410.1002/adma.202206654 ↗
17. 10.1002/anie.20210430410.1002/anie.202104304 ↗
18. 10.1021/jacs.1c0307110.1021/jacs.1c03071 ↗
19. 10.1002/smll.20210204610.1002/smll.202102046 ↗
20. 10.1016/j.biomaterials.2022.12183210.1016/j.biomaterials.2022.121832 ↗
21. 10.1002/anie.20190475110.1002/anie.201904751 ↗
22. 10.1016/j.cej.2021.13308910.1016/j.cej.2021.133089 ↗
23. 10.1021/acsnano.1c0107710.1021/acsnano.1c01077 ↗
24. 10.1002/smll.20200396910.1002/smll.202003969 ↗
25. 10.1021/jacs.6b0655810.1021/jacs.6b06558 ↗
26. 10.1021/acs.bioconjchem.2c0010010.1021/acs.bioconjchem.2c00100 ↗
27. 10.1021/acsnano.0c0993910.1021/acsnano.0c09939 ↗
28. 10.1002/ppsc.20200016610.1002/ppsc.202000166 ↗
29. 10.1021/acsanm.1c0189710.1021/acsanm.1c01897 ↗
30. 10.1016/j.molliq.2021.11549010.1016/j.molliq.2021.115490 ↗
31. 10.1021/acsami.1c1860110.1021/acsami.1c18601 ↗
32. 10.1016/j.biomaterials.2022.12182110.1016/j.biomaterials.2022.121821 ↗
33. 10.1002/adma.20210696710.1002/adma.202106967 ↗
34. 10.1002/adma.20210472910.1002/adma.202104729 ↗
35. 10.1016/j.jhazmat.2007.02.02210.1016/j.jhazmat.2007.02.022 ↗
36. 10.1016/j.jhazmat.2008.04.08010.1016/j.jhazmat.2008.04.080 ↗
37. 10.1002/anie.20200245210.1002/anie.202002452 ↗
38. 10.1021/acsnano.0c0097410.1021/acsnano.0c00974 ↗
39. 10.1002/adfm.20220501310.1002/adfm.202205013 ↗
40. 10.1016/j.nantod.2022.10162310.1016/j.nantod.2022.101623 ↗
41. 10.1016/j.biomaterials.2022.12170410.1016/j.biomaterials.2022.121704 ↗
42. 10.1016/j.apsb.2022.05.01110.1016/j.apsb.2022.05.011 ↗